Tue, June 8, 2021
Mon, June 7, 2021
Fri, June 4, 2021
Thu, June 3, 2021
Wed, June 2, 2021
Tue, June 1, 2021
Fri, May 28, 2021
Thu, May 27, 2021
Wed, May 26, 2021
Tue, May 25, 2021

Matthew Taylor Maintained (ABT) at Strong Buy with Decreased Target to $127 on, Jun 1st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-127-on-jun-1st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Taylor of UBS, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Decreased Target from $140 to $127 on, Jun 1st, 2021.

Matthew has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • James Mainwaring of "Atlantic Equities" Initiated at Hold and Held Target at $122 on, Thursday, April 15th, 2021
  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $115 on, Saturday, February 6th, 2021


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Travis Steed of "Barclays" Initiated at Buy and Held Target at $150 on, Tuesday, May 25th, 2021
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $140 on, Wednesday, April 21st, 2021
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $130 on, Thursday, March 11th, 2021

Publication Contributing Sources